References
- HanSYZhaoMBZhuangGBLiPPMarsdenia tenacissima extract restored gefitinib sensitivity in resistant non-small cell lung cancer cellsLung Cancer2012751303721757251
- GaoHLamustaJZhangWFTumor cell selective cytotoxicity and apoptosis induction by an herbal preparation from Brucea javanicaNorth Am J Med Sci2011426266
- ZhaoLLiCZhangYWenQRenDPhytochemical and biological activities of an anticancer plant medicine: Brucea javanicaAnticancer Agents Med Chem201414344045824066797
- LauSTLinZXZhaoMLeungPSBrucea javanica fruit induces cytotoxicity and apoptosis in pancreatic adenocarcinoma cell linesPhytother Res200822447748618386257
- LiuJHuangXETianGYPhase II study on safety and efficacy of Yadanzi® (Javanica oil emulsion injection) combined with chemotherapy for patients with gastric cancerAsian Pac J Cancer Prev20131432009201223679309
- LuYYHuangXECaoJPhase II study on Javanica oil emulsion injection (Yadanzi®) combined with chemotherapy in treating patients with advanced lung adenocarcinomaAsian Pac J Cancer Prev20131484791479424083745
- YangJLiSXieCAnti-inflammatory activity of ethyl acetate fraction of the seeds of Brucea javanicaJ Ethnopharmacol2013147244244623538165
- SudaKMitsudomiTRole of EGFR mutations in lung cancers: prognosis and tumor chemosensitivityArch Toxicol20158981227124025983263
- RolfoCGiovannettiEHongDSNovel therapeutic strategies for patients with NSCLC that do not respond to treatment with EGFR inhibitorsCancer Treat Rev2014408990100424953979
- SoucherayMCapellettiMPulidoIIntratumoral heterogeneity in EGFR mutant NSCLC results in divergent resistance mechanisms in response to EGFR tyrosine kinase inhibitionCancer Res201575204372438326282169
- YunCHBoggonTJLiYStructures of lung cancer-derived EGFR mutants and inhibitor complexes: mechanism of activation and insights into differential inhibitor sensitivityCancer Cell200711321722717349580
- LiuSVSubramaniamDCyriacGCEmerging protein kinase inhibitors for non-small cell lung cancerExpert Opin Emerg Drugs2014191516524354593
- ZhangWLeiPDongXXuCThe new concepts on overcoming drug resistance in lung cancerDrug Des Devel Ther20148735744
- ChenJHKimSHFanBWLiuCYHsiehCHFangKThe aqueous extract of Chinese medicinal herb Brucea javanica suppresses the growth of human liver cancer and the derived stem-like cells by apoptosisDrug Des Devel Ther20161020032013
- LienCYChuangTYHsuCHOral treatment with the herbal formula B307 alleviates cardiac toxicity in doxorubicin-treated mice via suppressing oxidative stress, inflammation, and apoptosisOncoTargets Ther2015811931210
- ShihJYGowCHYangPCEGFR mutation conferring primary resistance to gefitinib in non–small-cell lung cancerN Engl J Med2005353220720816014893
- NieYLLiuKXMaoXYLiYLLiJZhangMMEffect of injection of Brucea javanica oil emulsion plus chemoradiotherapy for lung cancer: a review of clinical evidenceJ Evid Based Med20125421622523557502
- ZhouCWuYLChenGErlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 studyLancet Oncol201112873574221783417
- LynchTJBellDWSordellaRActivating mutations in the epidermal growth factor receptor underlying responsiveness of non–small-cell lung cancer to gefitinibNew England J Med2004350212129213915118073
- SudaKMitsudomiTRole of EGFR mutations in lung cancers: prognosis and tumor chemosensitivityArch Toxicol2015891227124025983263
- ArmourAAWatkinsCLThe challenge of targeting EGFR: experience with gefitinib in nonsmall cell lung cancerEur Resp Rev201019117186196
- GhavamiSHashemiMAndeSRApoptosis and cancer: mutations within caspase genesJ Med Genet200946849751019505876
- FurfaroALTraversoNDomenicottiCThe Nrf2/HO-1 Axis in cancer cell growth and chemoresistanceOxid Med Cell Longev20162016195817426697129
- LiuTTMuLQDaiWWangCBLiuXYXiangDXPreparation, characterization, and evaluation of antitumor effect of Brucea javanica oil cationic nanoemulsionsInt J Nanomedicine2016112515252927330293